Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...
Researchers at National Jewish Health and colleagues have completed the first study comparing lung macrophages in multiple ...
In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...
A $42,000 grant from NASA and INBRE will further CF research, through a collaborative effort spanning to India and the United Kingdom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback